The following video is from this week's MarketFoolery podcast, in which host Chris Hill, along with Charly Travers, Mike Olsen, and Joe Magyer, discuss the latest business news. Immediately after the U.S. Supreme Court announced its 5-4 decision on President Obama's health-care law, shares of health-insurance companies dropped while shares of hospitals rose. In this segment, the guys analyze the hidden winners from the ruling and share why investors should keep their eyes on biotechnology companies like Momenta Pharmaceuticals and Becton, Dickinson.

While it pays a steady dividend, shares of pharmaceutical giant Amgen aren't trading at a bargain-basement price. To find those stocks, check out The Motley Fool's free report "2 Dirt Cheap Stocks With HUGE Dividends." You can get analysis of a market leader in payment systems and a high-yielding energy company by accessing this report. It won't be available forever, so click here -- it's free.

Chris Hill owns no shares of any of the companies mentioned. The Motley Fool owns shares of Momenta Pharmaceuticals. Motley Fool newsletter services have recommended buying shares of Becton and Momenta Pharmaceuticals. The Motley Fool has a disclosure policy. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.